← Eichor
Study identifier: NCT06715436 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Multiple Sclerosis and the Effects of Ketogenic Diet Therapy

Condition: Multiple Sclerosis, Relapsing-Remitting  ·  Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation

PhaseNA
Planned participants111
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

Multiple sclerosis (MS) is an inflammatory and immune-mediated neurological disease with multifactorial etiology. The specific etiopathogenetic mechanisms of MS are still unknown but it is clear that it results from a combination of genetic and environmental factors. Several studies have reported the possible role of diet as a risk factor for MS and its progression. To date, many dietary patterns and their association with MS have been studied, but data is still limited and inconclusive. Mediterranean Diet (MedDiet) has been associated with a lower risk of developing MS, compared to a Western-style diet. In one of investigators' studies, higher MedDiet adherence was associated with a 6-fold greater likelihood of having lower disease severity than those with low adherence. A significant restriction of carbohydrates (up to ketogenesis) can have beneficial effects on various parameters (inflammatory markers, oxidative stress, altered glucose metabolism) which are altered in subjects with MS. Ketogenic diet therapies (KDTs) have been recommended mainly for children with drug-resistant epilepsy, but in recent years they have been applied to Multiple Sclerosis. Preclinical studies in animal models evaluating the efficacy of KDTs in experimental autoimmune encephalomyelitis (EAE) found a beneficial effect of diet in slowing of disease progression, improvement of motor disability, reduction of inflammatory cytokines and reactive oxygen species. In a randomized study, improvements in …

This description comes directly from the study's public registry record.

Talk to the study team

Eleonora Tavazzi, MD  ·  0382380385  ·  eleonora.tavazzi@mondino.it

Cinzia Fattore, MD  ·  0382380385  ·  cinzia.fattore@mondino.it

Always discuss trial participation with your own doctor first.

Locations (1)

U.O.Sclerosi MultiplaPavia, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06715436